Proteomic analysis demonstrates that BRCA1-deficient epithelial ovarian cancer cell lines activate alternative pathways following exposure to cisplatin
Year: 2011
Type: article
Source: Gynecologic Oncology
Institutions: Magee-Womens Hospital, Inova Health System, Inova Fairfax Hospital
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1969224714
